Top Pharmaceuticals stocks in North America
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $722.31bn | 68.57 | 0.62% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $360.79bn | 16.07 | 3.18% |
MRKMerck & Co | $329.42bn | 56.6 | 2.31% |
ABBVAbbvie | $283.86bn | 31.76 | 3.73% |
AMGNAmgen | $166.38bn | 44.05 | 2.79% |
PFEPfizer | $158.72bn | 9.98 | 5.89% |
CELG RTBristol-Myers Squibb Co | $91.10bn | 0.01 | 4610.69% |
BMYBristol-Myers Squibb Co | $91.10bn | 11.98 | 5.14% |
GILDGilead Sciences | $82.18bn | 11.75 | 4.58% |
ZTSZoetis | $77.13bn | 32.26 | 0.92% |
MCKMcKesson | $72.78bn | 24.95 | 0.41% |
BIIBBiogen | $32.25bn | 23.95 | n/a |
TRULTrulieve Cannabis | CA$39.46bn | n/a | n/a |
HZNPHorizon Therapeutics | $26.63bn | 51.44 | n/a |
CAHCardinal Health | $24.24bn | 18.83 | 2.01% |
RPRXRoyalty Pharma | $16.78bn | 15.76 | 2.88% |
BMRNBiomarin Pharmaceutical | $15.39bn | 76.78 | n/a |
VTRSViatris | $13.29bn | 22.34 | 4.3% |
INCYIncyte | $11.91bn | 15.72 | n/a |